Nanomedicine based nanoparticles for neurological disorders

Bhasker Sriramoju, Rupinder K Kanwar, Jagat R Kanwar1

  • 1Nanomedicine- Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), School of Medicine, Faculty of Health, Deakin University, Waurn Ponds, Victoria 3217, Australia. jagat.kanwar@deakin.edu.au.

Summary

Nanotechnology offers novel drug delivery systems to overcome the blood-brain barrier for neurological disorders. Smart nanosystems show promise for targeted brain therapies, but long-term toxicity requires further study.